CD28, CD152

Industry

CPC
G01N2333/70521

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

GPHYSICS G01Measuring instruments G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES G01N2333/00Assays involving biological materials from specific organisms or of a specific nature

Current Industry

G01N2333/70521CD28, CD152

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for decreasing soluble immune receptor CD28
- Patent number 12,139,534
- Issue date Nov 12, 2024
- BIOND BIOLOGICS LTD.
- Motti Hakim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD8 T cell subsets as a biomarker for predicting non-fusion after s...
- Patent number 11,802,873
- Issue date Oct 31, 2023
- Charité—Universitätsmedizin Berlin
- Simon Reinke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of scoring a sample comprising tumor tissue
- Patent number 11,726,092
- Issue date Aug 15, 2023
- Novartis AG
- Naveen Dakappagari
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical comp...
- Patent number 11,578,128
- Issue date Feb 14, 2023
- AKESO PHARMACEUTICALS, INC.
- Baiyong Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PD1 and PDL-1 expression during progression from myelodysplastic sy...
- Patent number 11,287,428
- Issue date Mar 29, 2022
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Alan List
- G01 - MEASURING TESTING
Information Patent Grant
Methods of determining patient populations amenable to immunomodula...
- Patent number 11,215,616
- Issue date Jan 4, 2022
- NATIONAL INSTITUTES OF HEALTH (NIH), (DHHS), U.S. GOVERNMENT
- Lawrence Fong
- G01 - MEASURING TESTING
Information Patent Grant
Immune checkpoint molecular fitness profiling by mass spectrometry
- Patent number 11,204,355
- Issue date Dec 21, 2021
- Vanderbilt University
- Daniel C. Liebler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for expressing polypeptides on the surface...
- Patent number 10,829,771
- Issue date Nov 10, 2020
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination therapy for hepatocellular carcinoma
- Patent number 10,738,119
- Issue date Aug 11, 2020
- Health Research, Inc.
- Yasmin Thanavala
- G01 - MEASURING TESTING
Information Patent Grant
Method of scoring a sample comprising tumor tissue
- Patent number 10,705,088
- Issue date Jul 7, 2020
- Novartis AG
- Naveen Dakappagari
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Methods related to a structure of high-affinity human PD-1/PD-L2 co...
- Patent number 10,684,287
- Issue date Jun 16, 2020
- Chan Zuckerberg Biohub, Inc.
- Shaogeng Tang
- G01 - MEASURING TESTING
Information Patent Grant
Methods and compositions for obtaining a tuberculosis assessment in...
- Patent number 10,684,275
- Issue date Jun 16, 2020
- Becton, Dickinson and Company
- Smita Ghanekar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of predicting effect of treatment by PD-1/PD-L1 blockade usi...
- Patent number 10,585,100
- Issue date Mar 10, 2020
- Kyoto University
- Seishi Ogawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-1 antibodies
- Patent number 10,494,436
- Issue date Dec 3, 2019
- ADURO BIOTECH HOLDINGS, EUROPE B.V.
- Hans Van Eenennaam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunohistochemical proximity assay for PD-1 positive cells and PD-...
- Patent number 10,241,115
- Issue date Mar 26, 2019
- Merck Sharp & Dohme Corp.
- Robert H. Pierce
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD28 expression during lenalidomide immune modulation
- Patent number 10,241,113
- Issue date Mar 26, 2019
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Pearlie Burnette
- G01 - MEASURING TESTING
Information Patent Grant
Method of assaying an individual for immune impairment
- Patent number 10,119,959
- Issue date Nov 6, 2018
- The Board of Trustees of the Leland Stanford Junior University
- Shai S. Shen-Orr
- G01 - MEASURING TESTING
Information Patent Grant
Muteins of tear lipocalin and methods for obtaining the same
- Patent number 10,046,027
- Issue date Aug 14, 2018
- Pieris Pharmaceuticals GmbH
- Kristian Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-H7CR antibodies
- Patent number 9,790,277
- Issue date Oct 17, 2017
- The Johns Hopkins University
- Solomon Langermann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Muteins of human lipocalin 2 with affinity for CTLA-4
- Patent number 9,221,885
- Issue date Dec 29, 2015
- Pieris AG
- Gabriele Matschiner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muteins of tear lipocalin and methods for obtaining the same
- Patent number 9,221,887
- Issue date Dec 29, 2015
- Pieris AG
- Kristian Jensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muteins of tear lipocalin and methods for obtaining the same
- Patent number 8,313,924
- Issue date Nov 20, 2012
- Pieris AG
- Kristian Jensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for producing human antibodies with properties of agonist, a...
- Patent number 8,158,386
- Issue date Apr 17, 2012
- Li-Te Chin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for producing human antibodies to a self physiological recep...
- Patent number 8,021,860
- Issue date Sep 20, 2011
- Li-Te Chin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Surrogate therapeutic endpoint for anti-CTLA-4 based immunotherapy...
- Patent number 7,744,875
- Issue date Jun 29, 2010
- Medarex, Inc.
- Israel Lowy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for producing human antibodies to human CD152 with propertie...
- Patent number 7,494,779
- Issue date Feb 24, 2009
- Li-Te Chin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy o...
- Patent number 7,465,446
- Issue date Dec 16, 2008
- Medarex, Inc.
- Israel Lowy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Screening immunomodulatory agents by CTLA-4 upregulation
- Patent number 7,014,998
- Issue date Mar 21, 2006
- Yale University
- David M. Rothstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PREDICTIVE RESPONSE BIOMARKER DISCOVERY PROCESS
- Publication number 20250216382
- Publication date Jul 3, 2025
- HIFIBIO INC.
- Liang Schweizer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T CELL AND NK CELL ENGAGERS
- Publication number 20250138018
- Publication date May 1, 2025
- NextPoint Therapeutics, Inc.
- Bijan Etemad-Gilbertson
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND SYSTEMS FOR PREDICTING RESPONSE TO PD-1 AXIS DIRECTED T...
- Publication number 20250093356
- Publication date Mar 20, 2025
- Ventana Medical Systems, Inc.
- Eze O. AHANONU
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
CD28 BINDING ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF
- Publication number 20250052767
- Publication date Feb 13, 2025
- BioLegend, Inc.
- Cheng-Rui LI
- G01 - MEASURING TESTING
Information Patent Application
ANTI-PD-1 ANTIBODY AND USE THEREOF
- Publication number 20240425593
- Publication date Dec 26, 2024
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- DENGNIAN LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF
- Publication number 20240376203
- Publication date Nov 14, 2024
- Trustees of Tufts College
- Peter A. Bullock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28
- Publication number 20240309094
- Publication date Sep 19, 2024
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
- Publication number 20240219385
- Publication date Jul 4, 2024
- Allen Institute
- Thomas F. BUMOL
- G01 - MEASURING TESTING
Information Patent Application
MEANS AND METHODS FOR ASSESSING IMMUNOTHERAPY
- Publication number 20240159739
- Publication date May 16, 2024
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Mathias HEIKENWAELDER
- G01 - MEASURING TESTING
Information Patent Application
MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN A...
- Publication number 20230399403
- Publication date Dec 14, 2023
- BIONTECH SE
- Ugur SAHIN
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA
- Publication number 20230381309
- Publication date Nov 30, 2023
- IMMUNOVACCINE TECHNOLOGIES INC.
- Stephan FISET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF DIAGNOSING AND TREATING LUPUS
- Publication number 20230236188
- Publication date Jul 27, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- Laurence Celine Menard
- G01 - MEASURING TESTING
Information Patent Application
SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY
- Publication number 20230035730
- Publication date Feb 2, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY
- Publication number 20220357329
- Publication date Nov 10, 2022
- Accure Health Inc.
- Liyun Sang
- G01 - MEASURING TESTING
Information Patent Application
BIOMARKERS FOR DETERMINING THE EFFICACY OF IMMUNE CHECKPOINT INHIBI...
- Publication number 20220283167
- Publication date Sep 8, 2022
- ONO PHARMACEUTICAL CO., LTD.
- Hiroyoshi NISHIKAWA
- G01 - MEASURING TESTING
Information Patent Application
PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT...
- Publication number 20220107324
- Publication date Apr 7, 2022
- SAITAMA MEDICAL UNIVERSITY
- Hiroshi Kagamu
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20210269521
- Publication date Sep 2, 2021
- L&L BIOPHARMA CO., LTD.
- Jiajian LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
- Publication number 20210263034
- Publication date Aug 26, 2021
- Caris MPI, Inc.
- David Spetzler
- G01 - MEASURING TESTING
Information Patent Application
PD1 AND PDL-1 EXPRESSION DURING PROGRESSION FROM MYELODYSPLASTIC SY...
- Publication number 20210239703
- Publication date Aug 5, 2021
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Alan List
- G01 - MEASURING TESTING
Information Patent Application
METHODS RELATED TO A STRUCTURE OF HIGH-AFFINITY HUMAN PD-1/PD-L2 CO...
- Publication number 20210088528
- Publication date Mar 25, 2021
- The Board of Trustees of the Leland Stanford Junior University
- Shaogeng Tang
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28
- Publication number 20210047411
- Publication date Feb 18, 2021
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND KITS FOR EVALUATING CLINICAL OUTCOMES OF AUTOIMMUNE DIS...
- Publication number 20200408756
- Publication date Dec 31, 2020
- SINGAPORE HEALTH SERVICES PTE LTD.
- Salvatore ALBANI
- G01 - MEASURING TESTING
Information Patent Application
MOLECULAR PROFILING FOR CANCER
- Publication number 20200319191
- Publication date Oct 8, 2020
- Caris MPI, Inc.
- David Spetzler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF SCORING A SAMPLE COMPRISING TUMOR TISSUE
- Publication number 20200292550
- Publication date Sep 17, 2020
- Novartis AG
- Naveen DAKAPPAGARI
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
USE OF PD-1 AND TIM-3 AS A MEASURE FOR CD8+ CELLS IN PREDICTING AND...
- Publication number 20200264165
- Publication date Aug 20, 2020
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LARECHERCHE MEDICALE)
- Eric TARTOUR
- G01 - MEASURING TESTING
Information Patent Application
CD8 T CELL SUBSETS AS A BIOMARKER FOR PREDICTING NON-FUSION AFTER S...
- Publication number 20200182872
- Publication date Jun 11, 2020
- CHARITE-UNIVERSITATSMEDIZIN BERLIN
- Simon REINKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR DETERMINING THE POTENTIAL EFFICACY OF ANTICANCER TREATMENT
- Publication number 20200129566
- Publication date Apr 30, 2020
- Assistance Publique-Hopitaux de Paris
- Franck Carbonnel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMP...
- Publication number 20190185569
- Publication date Jun 20, 2019
- Baiyong LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF DIAGNOSING AND TREATING LUPUS
- Publication number 20190086405
- Publication date Mar 21, 2019
- Bristol-Myers Squibb Company
- Laurence Celine Menard
- G01 - MEASURING TESTING
Information Patent Application
MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
- Publication number 20190015477
- Publication date Jan 17, 2019
- Pieris Pharmaceuticals GmbH
- Kristian Jensen
- C07 - ORGANIC CHEMISTRY

CD28, CD152

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Methods and compositions for decreasing soluble immune receptor CD28

CD8 T cell subsets as a biomarker for predicting non-fusion after s...

Method of scoring a sample comprising tumor tissue

Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical comp...

PD1 and PDL-1 expression during progression from myelodysplastic sy...

Methods of determining patient populations amenable to immunomodula...

Immune checkpoint molecular fitness profiling by mass spectrometry

Compositions and methods for expressing polypeptides on the surface...

Combination therapy for hepatocellular carcinoma

Method of scoring a sample comprising tumor tissue

Methods related to a structure of high-affinity human PD-1/PD-L2 co...

Methods and compositions for obtaining a tuberculosis assessment in...

Method of predicting effect of treatment by PD-1/PD-L1 blockade usi...

Anti-PD-1 antibodies

Immunohistochemical proximity assay for PD-1 positive cells and PD-...

CD28 expression during lenalidomide immune modulation

Method of assaying an individual for immune impairment

Muteins of tear lipocalin and methods for obtaining the same

Anti-H7CR antibodies

Muteins of human lipocalin 2 with affinity for CTLA-4

Muteins of tear lipocalin and methods for obtaining the same

Muteins of tear lipocalin and methods for obtaining the same

Method for producing human antibodies with properties of agonist, a...

Method for producing human antibodies to a self physiological recep...

Surrogate therapeutic endpoint for anti-CTLA-4 based immunotherapy...

Method for producing human antibodies to human CD152 with propertie...

Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy o...

Screening immunomodulatory agents by CTLA-4 upregulation

Patents Applicationslast 30 patents

PREDICTIVE RESPONSE BIOMARKER DISCOVERY PROCESS

T CELL AND NK CELL ENGAGERS

METHODS AND SYSTEMS FOR PREDICTING RESPONSE TO PD-1 AXIS DIRECTED T...

CD28 BINDING ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF

ANTI-PD-1 ANTIBODY AND USE THEREOF

ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF

MEANS AND METHODS FOR ASSESSING IMMUNOTHERAPY

MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN A...

METHODS OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA

METHODS OF DIAGNOSING AND TREATING LUPUS

SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY

PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY

BIOMARKERS FOR DETERMINING THE EFFICACY OF IMMUNE CHECKPOINT INHIBI...

PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT...

BISPECIFIC ANTIBODY AND USE THEREOF

DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT

PD1 AND PDL-1 EXPRESSION DURING PROGRESSION FROM MYELODYSPLASTIC SY...

METHODS RELATED TO A STRUCTURE OF HIGH-AFFINITY HUMAN PD-1/PD-L2 CO...

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

METHODS AND KITS FOR EVALUATING CLINICAL OUTCOMES OF AUTOIMMUNE DIS...

MOLECULAR PROFILING FOR CANCER

METHOD OF SCORING A SAMPLE COMPRISING TUMOR TISSUE

USE OF PD-1 AND TIM-3 AS A MEASURE FOR CD8+ CELLS IN PREDICTING AND...

CD8 T CELL SUBSETS AS A BIOMARKER FOR PREDICTING NON-FUSION AFTER S...

METHOD FOR DETERMINING THE POTENTIAL EFFICACY OF ANTICANCER TREATMENT

ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMP...

METHODS OF DIAGNOSING AND TREATING LUPUS

MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME